NCT01661270 - A Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy | Biotech Hunter

Enrollment

332

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

July 31, 2015

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG

Aflibercept

Pharmaceutical form: Concentrate for Solution for infusion; Route of administration: Intravenous

DRUG

Placebo

Pharmaceutical form: Concentrate for Solution for infusion; Route of administration: Intravenous

Trial Locations (37)

10043

Investigational Site Number 158003, Taipai

100071

Investigational Site Number 156003, Beijing

100142

Investigational Site Number 156001, Beijing

100210

Investigational Site Number 156002, Beijing

100853

Investigational Site Number 156004, Beijing

110001

Investigational Site Number 156014, Shenyang

119228

Investigational Site Number 702002, Singapore

150081

Investigational Site Number 156015, Harbin

169610

Investigational Site Number 702001, Singapore

200032

Investigational Site Number 156006, Shanghai

Investigational Site Number 156007, Shanghai

210002

Investigational Site Number 156012, Nanjing

210029

Investigational Site Number 156013, Nanjing

300060

Investigational Site Number 156005, Tianjin

310003

Investigational Site Number 156010, Hangzhou

310009

Investigational Site Number 156011, Hangzhou

310016

Investigational Site Number 156009, Hangzhou

350014

Investigational Site Number 156021, Fuzhou

400038

Investigational Site Number 156020, Chongqing

430022

Investigational Site Number 156019, Wuhan

430030

Investigational Site Number 156018, Wuhan

510060

Investigational Site Number 156008, Guangzhou

610041

Investigational Site Number 156016, Chengdu

710032

Investigational Site Number 156017, Xi'an

Unknown

Investigational Site Number 344002, Hong Kong

Investigational Site Number 344001, Shatin, Nt

Investigational Site Number 392006, Amagasaki-Shi

Investigational Site Number 392003, Bunkyō City

Investigational Site Number 392004, Bunkyō City

Investigational Site Number 392009, Gifu

Investigational Site Number 392002, Kitaadachi-Gun

Investigational Site Number 392001, Kobe

Investigational Site Number 392005, Kochi

Investigational Site Number 392007, Kumamoto

Investigational Site Number 392008, Nagakute-Shi

Investigational Site Number 392010, Takatsuki-Shi

Investigational Site Number 158002, Taipei